Turning Point Brands Reiterates FY26 Modern Oral Gross Sales Outlook Range Of $330M - $350M, Net Sales Guidance Of $260M - $270M

Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, today announced it is reaffirming its full-year 2026 Modern Oral gross sales guidance range of $330 million to $350 million and net sales guidance of $260 million to $270 million. The Company is tightening its full-year EBITDA guidance range to $70 million to $80 million from $70 million to $90 million, assuming no margin benefit from onshoring manufacturing until 2027 and prolonged, higher freight costs.